Bastatas, Francis .
HRN: 25-90-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/23/2024
09/30/2024
IV
500mg
Q6hr
T/C Perforated Viscus
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes